BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Press Releases

  BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced Melanoma

  July 30, 2024

   · 

  12 min read
• Press Releases

  Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024

  July 30, 2024

   · 

  1 min read
• Press Releases

  Foresight Diagnostics Expands Series B Financing to $73.75 Million to Advance the Foresight CLARITY™ MRD Platform

  July 30, 2024

   · 

  3 min read
• Press Releases

  AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery Capabilities

  July 30, 2024

   · 

  3 min read
• Press Releases

  Genexys BioMed Awarded $320K SBIR Grant to Advance Novel Cystic Fibrosis Gene Therapy

  July 30, 2024

   · 

  3 min read
• Press Releases

  GLP-1 Drug Liraglutide May Protect Against Dementia

  July 30, 2024

   · 

  6 min read
• Press Releases

  VitalHub Corp. to Acquire MedCurrent Corporation

  July 30, 2024

   · 

  8 min read
• Press Releases

  Ocular Therapeutix™ Announces First Patients Enrolled in Phase 3 SOL-R Wet AMD Study

  July 30, 2024

   · 

  9 min read
• Press Releases

  Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024

  July 30, 2024

   · 

  1 min read
• Press Releases

  Intellia Therapeutics Receives Authorization to Initiate Phase 1/2 Clinical Trial of NTLA-3001 for the Treatment of Alpha-1 Antitrypsin Deficiency

  July 30, 2024

   · 

  6 min read